v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net (loss) income $ (1,034) $ 13,948
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization expense 45,395 45,421
Equity in income of joint ventures (3,231) (3,706)
Stock-based compensation expense 7,274 6,968
Elimination of unrealized loss on sales to joint ventures 107 0
Deferred taxes (1,784) (12,934)
Unrealized foreign exchange loss (gain) 120 (1,209)
Changes in assets and liabilities:    
Accounts receivable, net (16,652) 37,828
Inventories (177) (5,026)
Other assets (6,304) (9,868)
Accounts payable and accrued liabilities 11,468 (38,370)
Other liabilities (2,547) 13,391
Income taxes, net (8,628) (3,983)
Dividends received from joint ventures 4,662 0
Other (3,385) (951)
Net cash provided by operating activities 25,284 41,509
Cash flows from investing activities:    
Capital expenditures (25,764) (33,112)
Net cash used in investing activities (25,764) (33,112)
Cash flows from financing activities:    
Cash pledged for collateral deposits, net 0 (415)
Repurchase of common stock (19,998) (10,020)
Payment of withholding taxes on stock-based compensation plans (4,880) (2,588)
Repayment of financed insurance premium 0 (1,739)
Repayments of finance leases (518) (342)
Net cash used in financing activities (25,396) (15,104)
Effect of exchange rate changes on cash and cash equivalents (824) 2,218
Net decrease to cash and cash equivalents and restricted cash (26,700) (4,489)
Cash and cash equivalents and restricted cash at beginning of period 197,473 184,663
Cash and cash equivalents and restricted cash at end of period $ 170,773 $ 180,174